ADNRX:NASDAQ
American Beacon ARK Transformational Innovation Fund R6 Class – ADNRX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 13.54 | 0.36 (+2.73%) | 10.87 - 18.37 | -- |
Market data as of 12:00AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - ADNRX
The investment seeks long-term growth of capital.
Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are principally in developed markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.
Growth of $10,000 (10 Years)
| Total Return | -- |
|---|
| Yield (Trailing 12 Mo.) | 0.00% |
|---|
| Expense Ratio | 1.13% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $0.00 |
|---|
| Management Tenure | 8 Years |
|---|
| Fund Inception | 10/28/2020 |
|---|
Trailing Total Returns - ADNRX
as of 02/28/2025
| Timeframe | ADNRX | S&P 500 | Mid-Cap Growth |
|---|
| 1 Month | -11.30% | -1.30% | -5.95% |
|---|
| 3 Month | -3.77% | -0.97% | -7.41% |
|---|
| Year-to-Date | -1.80% | 1.44% | -0.92% |
|---|
| 1 Year | 9.51% | 18.41% | 8.25% |
|---|
| 3 Year | -6.68% | 12.55% | 4.61% |
|---|
| 5 Year | 1.63% | 16.85% | 10.24% |
|---|
| 10 Year | -- | 12.98% | 9.46% |
|---|
| Since Inception | -- | 11.12% | -- |
|---|
Sector Allocation - ADNRX
as of 02/28/2025
| Basic Materials | | 0.00% |
|---|
| Consumer Cyclical | | 17.22% |
|---|
| Financial Services | | 14.91% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 0.00% |
|---|
| Healthcare | | 22.49% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 19.57% |
|---|
| Energy | | 0.00% |
|---|
| Industrials | | 2.36% |
|---|
| Technology | | 23.45% |
|---|
Asset Allocation - ADNRX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | 90.52 | 90.52 |
|---|
| Bond | -- | | | 0.00 | 0.00 |
|---|
| Other | -- | | | 0.00 | 0.00 |
|---|
| Foreign Stock | -- | | | 8.47 | 8.47 |
|---|
| Foreign Bond | -- | | | 0.00 | 0.00 |
|---|
| Total | -- | | | 98.99 | 98.99 |
|---|
| Cash | -- | | | 1.02 | 1.02 |
|---|
| Total Net Assets | $180.56M |
|---|
| Total Stock Holdings | 33 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - ADNRX
as of 02/28/2025
Valuation & Growth - ADNRX
as of 02/28/2025
| Valuation | ADNRX | Category Range |
|---|
| Price/Earnings | 52.69 | |
|---|
| Price/Book | 6.06 | |
|---|
| Price/Sales | 7.52 | |
|---|
| Price/Cash Flow | 34.53 | |
|---|
| Dividend Yield | 0.01 | |
|---|
| LT Earnings | 10.2 | |
|---|
| Historical Earnings | | |
|---|
| Sales Growth | 14.27 | |
|---|
| Cash-Flow Growth | 26.12 | |
|---|
| Book-Value Growth | 0.54 | |
|---|
